Company Filing History:
Years Active: 2024-2025
Title: Samareh Azeredo Da Silveira Lajaunias: Innovator in Liposome Technology
Introduction
Samareh Azeredo Da Silveira Lajaunias is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of liposome technology, particularly in the development of compositions aimed at inhibiting biofilm formation and treating pneumonia. With two patents to his name, Lajaunias is recognized for his innovative approaches to addressing medical challenges.
Latest Patents
Lajaunias's latest patents include a composition for inhibiting biofilm formation. This invention involves a single empty liposome, which may consist of cholesterol and sphingomyelin, or a mixture of empty liposomes. The composition is designed to prevent or reduce biofilm formation, which is crucial in various medical applications. His second patent focuses on the treatment of pneumonia, utilizing a mixture of empty liposomes that includes cholesterol and sphingomyelin. This composition is intended for adjunctive treatment in human patients suffering from pneumonia.
Career Highlights
Samareh Azeredo Da Silveira Lajaunias works at Combioxin SA, a company dedicated to developing innovative therapeutic solutions. His work has been instrumental in advancing liposome technology, which has significant implications for medical treatments.
Collaborations
Lajaunias collaborates with Frédéric Lajaunias, contributing to the innovative research and development efforts at Combioxin SA.
Conclusion
Samareh Azeredo Da Silveira Lajaunias is a prominent inventor whose work in liposome technology has the potential to transform medical treatments. His patents reflect a commitment to addressing critical health issues through innovative solutions.